By Arsen Sebiskveradze

MIT scientists have developed a miniature ultrasound system that is radically changing the early diagnosis of breast cancer. The new device is so small that it can be used both in a doctor’s office and at home, making the technology especially useful for patients in high-risk groups.

The device aims for the timely detection of so-called “interval cancers.” These represent the 20%–30% of aggressive tumors that develop in the period between scheduled mammograms. When diagnosed at an early stage, the patient survival rate is nearly 100%; however, in cases of late detection, this figure drops sharply to 25%.

Current ultrasound machines are bulky, expensive, and require highly qualified technicians to operate, which limits diagnostic accessibility for patients. MIT’s new portable system removes these barriers.

The device’s compact size and ease of use allow for continuous monitoring of individuals at high risk of rapid disease progression. This MIT innovation establishes a completely new standard of diagnostics in medical practice.

We spoke with the co-author of this breakthrough innovation, Professor Canan Dağdeviren. Canan Dağdeviren is a physicist and an Associate Professor at the Massachusetts Institute of Technology (MIT), where she currently holds the position of LG Career Development Professor of Media Arts and Sciences.